Clinical Trials Update: April 17, 2006
Urinary Incontinence Ulcerative Colitis Erectile Dysfunction
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
Pivotal Research Centers is conducting a research study with an investigational medication for overactive bladders in women.
Eligible candidates should be women ages 18-65 who urinate more than eight times in a 24-hour period.
Participants will receive at no cost a study-related drug and physical and will be compensated for their time and travel.
The research site is in Peoria, Ariz.
This study is designed to establish the safety and tolerability of a single dose of MDX-1100 in patients with ulcerative colitis.
Successful canndidates should be 18 years or older with active ulcerative colitis and a DAI no less than 4 and no greater than 9. They should not have a history of colectomy, partial colectomy, current ostomy, or pouchitis. Other criteria also apply.
The research site is in Los Angeles.
This is a research study of an approved oral medication for erectile dysfunction (ED).
Gay men who are experiencing ED may qualify, if they are in a stable relationship with one male partner.
Study-related care and medication will be provided at no charge to qualified volunteers.
The research site is in Houston, Tex.
Copyright 2006 CenterWatch. All rights reserved.